Clinical Trial Update: Multicenter Selective Lymphadenectomy Trial (MSLT) [Phase 3]

View source ↗

Summary

Phase 3 multicenter trial evaluating selective lymphadenectomy in melanoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Saint John's Cancer Institute | Conditions: Melanoma | Phase 3 | Status: COMPLETED